14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.401 $0.81 Friday, 3rd May 2024 RGBP stock ended at $0.660. This is 15.79% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 25.45% from a day low at $0.550 to a day high of $0.690.
90 days $0.401 $1.05
52 weeks $0.401 $2.19

Historical Regen Biopharma Inc prices

Date Open High Low Close Volume
Feb 02, 2016 $0.120 $0.138 $0.116 $0.122 110 392
Feb 01, 2016 $0.135 $0.136 $0.116 $0.136 18 500
Jan 29, 2016 $0.130 $0.130 $0.116 $0.127 60 442
Jan 28, 2016 $0.120 $0.120 $0.115 $0.120 14 620
Jan 27, 2016 $0.119 $0.120 $0.116 $0.120 36 653
Jan 26, 2016 $0.130 $0.132 $0.118 $0.120 132 299
Jan 25, 2016 $0.123 $0.130 $0.111 $0.118 99 326
Jan 22, 2016 $0.117 $0.128 $0.115 $0.117 58 862
Jan 21, 2016 $0.110 $0.146 $0.110 $0.129 47 928
Jan 20, 2016 $0.130 $0.140 $0.109 $0.130 89 635
Jan 19, 2016 $0.144 $0.144 $0.110 $0.127 386 783
Jan 15, 2016 $0.130 $0.130 $0.110 $0.120 127 728
Jan 14, 2016 $0.140 $0.149 $0.125 $0.133 37 722
Jan 13, 2016 $0.150 $0.150 $0.125 $0.134 163 645
Jan 12, 2016 $0.138 $0.154 $0.122 $0.147 661 943
Jan 11, 2016 $0.140 $0.154 $0.122 $0.133 177 105
Jan 08, 2016 $0.155 $0.155 $0.140 $0.145 92 398
Jan 07, 2016 $0.140 $0.155 $0.140 $0.155 77 181
Jan 06, 2016 $0.150 $0.150 $0.141 $0.145 58 591
Jan 05, 2016 $0.150 $0.160 $0.145 $0.150 73 155
Click to get the best stock tips daily for free!

About Regen Biopharma Inc

Regen Biopharma Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La ... RGBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT